The edition · Internal Medicine
Comorbidity amplifies heatstroke risk at a given temperature; fewer than one in seven with fatty liver and risky drinking got alcohol treatment
A large case-control study of heat and chronic disease burden, a cohort linking cannabis use disorder to higher mortality, a look at PSA testing and life expectancy, and a treatment gap in steatotic liver disease.
The edition in brief
A Japanese claims-based case-control study of 21,724 heatstroke cases and 65,172 matched controls found that the association between wet-bulb globe temperature and heatstroke was stronger with more chronic conditions: at 33°C against a reference of 25°C, the odds ratio was 2.04 with no conditions and 2.66 with four, after adjusting for heat-sensitive medicines. In a matched Colorado cohort of 100,140 people, cannabis use disorder was associated with higher all-cause mortality (HR 1.52, 1.30 to 1.77), mainly injury, overdose, accidents and cancer, but not cardiovascular or respiratory death; as an observational study, it cannot show causation. In US linked VA-Medicare data, PSA testing among men aged 80 and over was lower in VA primary care than in fee-for-service Medicare (IRR 0.70), suggesting testing tracked likelihood of benefit more closely there. In 608 adults with steatotic liver disease, 14.5% reported hazardous alcohol use and 39.1% mild-to-moderate use, yet only 13.4% of those with any alcohol use received treatment; treatment was associated with falling AUDIT-C scores. The pearl covers medicines that impair heat tolerance.
Chronic disease burden steepens the link between heat and heatstroke
Consider multimorbidity as a marker of heat vulnerability when counselling patients before and during hot weather.
Cannabis use disorder was associated with higher all-cause mortality
Consider cannabis use disorder as a marker of higher mortality risk and look for co-occurring substance use and injury risk.
PSA testing tracked life expectancy more closely in VA primary care than in Medicare
Review PSA testing in older men against life expectancy and the likelihood that screening would help them.
Review heat-sensitive medicines before the hot season
Before the hot season, review diuretics, antihypertensives and anticholinergic drugs in vulnerable patients and give them a heat plan.
Fewer than one in seven adults with steatotic liver disease and alcohol use received treatment
If you screen for alcohol in fatty liver disease, make sure a positive screen leads to a treatment offer, not just a score in the chart.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for internal medicine, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free